Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
91,525,982
-
Share change
-
+5,915,168
-
Total reported value
-
$374,618,138
-
Put/Call ratio
-
22%
-
Price per share
-
$4.10
-
Number of holders
-
173
-
Value change
-
+$24,359,321
-
Number of buys
-
75
-
Number of sells
-
65
Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q1 2022
As of 31 Mar 2022,
ANTARES PHARMA INC - COM (ATRS) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,525,982 shares.
The largest 10 holders included
BlackRock Inc., Rubric Capital Management LP, VANGUARD GROUP INC, Sargent Investment Group, LLC, AMUNDI, STATE STREET CORP, Stonepine Capital Management, LLC, Russell Investments Group, Ltd., GEODE CAPITAL MANAGEMENT, LLC, and FIRST WILSHIRE SECURITIES MANAGEMENT INC.
This page lists
173
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.